Literature DB >> 27890334

Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review.

C E French1, C Coope2, L Conway3, J P T Higgins1, J McCulloch4, G Okoli5, B C Patel4, I Oliver3.   

Abstract

BACKGROUND: In recent years, infections with carbapenemase-producing Enterobacteriaceae (CPE) have been increasing globally and present a major public health challenge. AIM: To review the international literature: (i) to describe CPE outbreaks in acute hospital settings globally; and (ii) to identify the control measures used during these outbreaks and report on their effectiveness.
METHODS: A systematic search of MEDLINE and EMBASE databases, abstract lists for key conferences and reference lists of key reviews was undertaken, and information on unpublished outbreaks was sought for 2000-2015. Where relevant, risk of bias was assessed using the Newcastle-Ottawa scale. A narrative synthesis of the evidence was conducted.
FINDINGS: Ninety-eight outbreaks were eligible. These occurred worldwide, with 53 reports from Europe. The number of cases (CPE infection or colonization) involved in outbreaks varied widely, from two to 803. In the vast majority of outbreaks, multi-component infection control measures were used, commonly including: patient screening; contact precautions (e.g. gowns, gloves); handwashing interventions; staff education or monitoring; enhanced environmental cleaning/decontamination; cohorting of patients and/or staff; and patient isolation. Seven studies were identified as providing the best-available evidence on the effectiveness of control measures. These demonstrated that CPE outbreaks can be controlled successfully using a range of appropriate, commonly used, infection control measures. However, risk of bias was considered relatively high for these studies.
CONCLUSION: The findings indicate that CPE outbreaks can be controlled using combinations of existing measures. However, the quality of the evidence base is weak and further high-quality research is needed, particularly on the effectiveness of individual infection control measures. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute settings; Carbapenem-resistant Enterobacteriaceae; Carbapenemase-producing Enterobacteriaceae; Infection control; Outbreak

Mesh:

Substances:

Year:  2016        PMID: 27890334     DOI: 10.1016/j.jhin.2016.10.006

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  22 in total

1.  The use of multi-pronged screening strategy to understand the epidemiology of carbapenemase-producing Enterobacteriaceae in Hong Kong: transition from epidemic to endemic setting.

Authors:  Shuk- Ching Wong; Veronica Wing- Man Chan; Germaine Kit-Ming Lam; Christine Ho-Yan AuYeung; Elaine Yin-Ling Leung; Simon Yung-Chun So; Jonathan Hon-Kwan Chen; Siddharth Sridhar; Anthony Raymond Tam; Ivan Fan-Ngai Hung; Pak- Leung Ho; Kwok- Yung Yuen; Vincent Chi-Chung Cheng
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-05       Impact factor: 3.267

2.  Evaluation of CARBA PAcE, a novel rapid test for detection of carbapenemase-producing Enterobacterales.

Authors:  Janko Sattler; Anne Brunke; Axel Hamprecht
Journal:  J Med Microbiol       Date:  2021-02       Impact factor: 2.472

3.  A hospital-based matched case-control study to identify risk factors for clinical infection with OXA-48-producing Klebsiella pneumoniae in rectal carriers.

Authors:  A Madueño; J Gonzalez Garcia; A Aguirre-Jaime; M Lecuona
Journal:  Epidemiol Infect       Date:  2017-07-17       Impact factor: 4.434

4.  Extensive colonization with carbapenemase-producing microorganisms in Romanian burn patients: infectious consequences from the Colectiv fire disaster.

Authors:  L E Pirii; A W Friedrich; J W A Rossen; W Vogels; G I J M Beerthuizen; M K Nieuwenhuis; A M D Kooistra-Smid; E Bathoorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-23       Impact factor: 3.267

Review 5.  Carbapenem Resistance: A Review.

Authors:  Francis S Codjoe; Eric S Donkor
Journal:  Med Sci (Basel)       Date:  2017-12-21

6.  Control of Carbapenemase-producing Enterobacteriaceae: Beyond the Hospital.

Authors:  Vincent C C Cheng; Shuk-Ching Wong; Sally C Y Wong; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  EClinicalMedicine       Date:  2019-01-07

7.  CP-CRE/non-CP-CRE Stratification And CRE Resistance Mechanism Determination Help In Better Managing CRE Bacteremia Using Ceftazidime-Avibactam And Aztreonam-Avibactam.

Authors:  Hua Zou; Sen-Jie Xiong; Qiu-Xia Lin; Meng-Lu Wu; Si-Qiang Niu; Shi-Feng Huang
Journal:  Infect Drug Resist       Date:  2019-09-23       Impact factor: 4.003

8.  Implementing a toolkit for the prevention, management and control of carbapenemase-producing Enterobacteriaceae in English acute hospitals trusts: a qualitative evaluation.

Authors:  Annegret Schneider; Caroline Coope; Susan Michie; Richard Puleston; Susan Hopkins; Isabel Oliver
Journal:  BMC Health Serv Res       Date:  2019-10-12       Impact factor: 2.655

9.  Bacterial characteristics of carbapenem-resistant Enterobacteriaceae (CRE) colonized strains and their correlation with subsequent infection.

Authors:  Qun Lin; Yue Wang; Jing Yu; Shusheng Li; Yicheng Zhang; Hui Wang; Xiaoquan Lai; Dong Liu; Liyan Mao; Ying Luo; Guoxing Tang; Zhongju Chen; Ziyong Sun
Journal:  BMC Infect Dis       Date:  2021-07-02       Impact factor: 3.090

10.  Novel Enterobacter Lineage as Leading Cause of Nosocomial Outbreak Involving Carbapenemase-Producing Strains.

Authors:  Racha Beyrouthy; Marion Barets; Elodie Marion; Cédric Dananché; Olivier Dauwalder; Frédéric Robin; Lauraine Gauthier; Agnès Jousset; Laurent Dortet; François Guérin; Thomas Bénet; Pierre Cassier; Philippe Vanhems; Richard Bonnet
Journal:  Emerg Infect Dis       Date:  2018-08       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.